SCHEMBL16467017

SCHEMBL16467017

CCCC(=O)Oc1cccc2c1O2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
RECQL P46063 1/20 0.44
ALOX15 P16050 1/20 0.43
LMNA P02545 1/20 0.43
MTNR1A P48039 4/20 0.41
MTNR1B P49286 2/20 0.41
POLM Q9NP87 2/20 0.41
POLK Q9UBT6 2/20 0.41
POLL Q9UGP5 2/20 0.41
POLH Q9Y253 2/20 0.41
BCL9 O00512 1/20 0.39
CTNNB1 P35222 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HTR1A P08908 1/20 0.37
DRD2 P14416 1/20 0.37
DRD1 P21728 1/20 0.37
HTR2A P28223 1/20 0.37
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11358917 0.83 MTNR1A (0.59) KMT2AKDM4EMEN1RECQLLMNA
SCHEMBL9312497 0.79 KMT2A (0.59) KMT2AKDM4EMEN1RECQLALOX15
SCHEMBL22141048 0.78 KMT2A (0.50) KMT2AKDM4EMEN1RECQLALOX15
SCHEMBL7559262 0.76 LMNA (0.43) KMT2AKDM4EMEN1RECQLALOX15
SCHEMBL16466810 0.75 MTNR1A (0.40) KMT2AKDM4EMEN1MTNR1AALDH1A1
SCHEMBL5316653 0.75 IAPP (0.50) KMT2AKDM4EMEN1RECQLALOX15
SCHEMBL15548829 0.74 KMT2A (0.54) KMT2AKDM4EMEN1RECQLALOX15
SCHEMBL28834444 0.73 KDM4E (0.46) KMT2AKDM4EMEN1RECQLALOX15
SCHEMBL27942332 0.73 MEN1 (0.50) KMT2AKDM4EMEN1RECQLALOX15
SCHEMBL29373398 0.73 ALDH1A1 (0.58) KMT2AKDM4EMEN1RECQLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2837630-B1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE ASYMCHEM LAB TIANJIN CO LTD (CN) 2016-11-23 EP disclosed
US-9365573-B2 Method for synthesizing sapropterin dihydrochloride ASYMCHEM LABORATORIES (TIANJIN) CO., LTD (CN) 2016-06-14 US disclosed
US-20150105555-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD (CN) 2015-04-16 US disclosed
EP-2837630-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE Asymchem Laboratories (Tianjin) Co., Ltd (CN) 2015-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105555-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE CYP51A1, DHCR7, LSS KMT2A 4271/4885KDM4E 4409/4885MEN1 1207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.